Concepedia

Shane W Kaski

SW

5

Publications

131

Citations

5

H-Index

2018

Active since

Affiliations

West Virginia University(Current)

University of North Carolina at Chapel Hill

Shane W Kaski is an author at West Virginia University specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

2018–2021

5

Publications

5

Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine

Shane W Kaski, Allison White, Joshua Gross et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 54 citations · Full text

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist

Yan Zhou, Kevin B. Freeman, Vincent Setola et al. · Handbook of experimental pharmacology · 2021 · 25 citations · Full text

, , +10

Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior

Joshua Gross, Shane W Kaski, Karl T. Schmidt et al. · Neuropsychopharmacology · 2019 · 23 citations · Full text

, , +13

Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants

Joshua Gross, Shane W Kaski, Adam B. Schroer et al. · Journal of Psychopharmacology · 2018 · 19 citations · Full text

Development of Full Sweet, Umami, and Bitter Taste Responsiveness Requires Regulator of G protein Signaling-21 (RGS21)

Adam B. Schroer, Joshua Gross, Shane W Kaski et al. · Chemical Senses · 2018 · 10 citations · Full text

, , +12

Rows per page

1–5 of 5